Mapping analysis to predict the associated EuroQol five-dimension three-level utility values from the Oxford Knee Score : a prediction and validation study.

Clement, Nick D; Afzal, Irrum; Peacock, Christian J H; MacDonald, Deborah; Macpherson, Gavin J; Patton, James T; Asopa, Vipin; Sochart, David H et al. · Bone Jt Open · 2022

retrospective_cohort · Level III

Where this comes from

Abstract

The aims of this study were to assess mapping models to predict the three-level version of EuroQoL five-dimension utility index (EQ-5D-3L) from the Oxford Knee Score (OKS) and validate these before and after total knee arthroplasty (TKA). A retrospective cohort of 5,857 patients was used to create the prediction models, and a second cohort of 721 patients from a different centre was used to validate the models, all of whom underwent TKA. Patient characteristics, BMI, OKS, and EQ-5D-3L were collected preoperatively and one year postoperatively. Generalized linear regression was used to formulate the prediction models. There were significant correlations between the OKS and EQ-5D-3L preoperatively (<i>r</i> = 0.68; p < 0.001) and postoperatively (<i>r</i> = 0.77; p < 0.001) and for the change in the scores (<i>r</i> = 0.61; p < 0.001). Three different models (preoperative, postoperative, and change) were created. There were no significant differences between the actual and predicted mean EQ-5D-3L utilities at any timepoint or for change in the scores (p > 0.090) in the validation cohort. There was a significant correlation between the actual and predicted EQ-5D-3L utilities preoperatively (<i>r</i> = 0.63; p < 0.001) and postoperatively (<i>r</i> = 0.77; p < 0.001) and for the change in the scores (<i>r</i> = 0.56; p < 0.001). Bland-Altman plots demonstrated that a lower utility was overestimated, and higher utility was underestimated. The individual predicted EQ-5D-3L that was within ± 0.05 and ± 0.010 (minimal clinically important difference (MCID)) of the actual EQ-5D-3L varied between 13% to 35% and 26% to 64%, respectively, according to timepoint assessed and change in the scores, but was not significantly different between the modelling and validation cohorts (p ≥ 0.148). The OKS can be used to estimate EQ-5D-3L. Predicted individual patient utility error beyond the MCID varied from one-third to two-thirds depending on timepoint assessed, but the mean for a cohort did not differ and could be employed for this purpose. Cite this article: <i>Bone Jt Open</i> 2022;3(7):573-581.

Anatomy